Format

Send to

Choose Destination
Viruses. 2019 May 15;11(5). pii: E441. doi: 10.3390/v11050441.

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma.

Author information

1
Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, F-67000 Strasbourg, France. thomas.baumert@unistra.fr.
2
Université de Strasbourg, F-67000 Strasbourg, France. thomas.baumert@unistra.fr.
3
Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Nouvel Hôpital Civil, F-67000 Strasbourg, France. thomas.baumert@unistra.fr.
4
Liver Tumor Translational Research Program, Harold C. Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Yujin.Hoshida@UTSouthwestern.edu.

Abstract

Chronic hepatitis C virus (HCV) infection is a major cause of liver disease and hepatocellular carcinoma (HCC)-the second leading, and rising, cause of death due to cancer world-wide [...].

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center